查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1788338

全球前哨淋巴結切片市場

Sentinel Node Biopsy
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 203 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年全球前哨淋巴結活體組織切片市場規模將達到 13 億美元

全球前哨淋巴結活體組織切片市場規模預計在2024年達到8.293億美元，預計在2024-2030年的分析期內將以7.1%的複合年成長率成長，到2030年將達到13億美元。本報告分析的細分市場之一－手術器械，預計其複合年成長率將達到7.9%，到分析期結束時規模將達到7.322億美元。影像劑細分市場在分析期間內的複合年成長率預計為6.2%。

美國市場規模估計為 2.18 億美元，中國市場預計複合年成長率為 6.9%

美國哨兵淋巴結切片市場規模預計在2024年達到2.18億美元。預計到2030年，作為世界第二大經濟體的中國市場規模將達到2.003億美元，在2024-2030年的分析期內，複合年成長率為6.9%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為6.7%和5.9%。在歐洲，預計德國市場的複合年成長率為5.6%。

全球前哨淋巴結活體組織切片市場—主要趨勢和促進因素摘要

為什麼前哨淋巴結切片成為癌症診斷的重要程序？

前哨淋巴結活體組織切片 (SNB) 是一種微創外科手術，用於確定癌症的擴散範圍，特別適用於乳癌和黑色素瘤。透過識別和分析癌細胞可能到達的第一個淋巴結（前哨淋巴結），SNB 可協助醫生評估癌細胞轉移情況，而無需進行完整的淋巴結清除術。該技術因其能夠減少淋巴水腫等併發症，同時保持較高的診斷準確性，正日益普及。隨著全球癌症發生率的上升，以及早期檢測在提高存活率方面發揮的關鍵作用，醫療機構對前哨淋巴結活體組織切片的需求日益成長。此外，影像和分子診斷技術的進步也進一步提高了 SNB 的準確性和可靠性。

哪些技術創新正在改進前哨淋巴結活體組織切片技術？

放射性追蹤劑技術、螢光導引手術和分子影像的最新進展正在徹底改變前哨淋巴結活體組織切片。混合示蹤劑（結合放射性和螢光染料）的使用提高了檢出率，使外科醫生能夠精確定位前哨淋巴結的位置。人工智慧輔助病理分析進一步提高了切片檢查結果的準確性，從而有助於更好地進行癌症分期和製定治療計劃。此外，機器人輔助前哨淋巴結活體組織切片正在研究中，以提高準確性並最大限度地減少患者創傷。這些技術突破使前哨淋巴結活體組織切片更加高效和準確，使其在腫瘤學實踐中的應用日益廣泛。

哪些醫學領域將推動前哨淋巴結活體組織切片的發展？

乳癌診斷仍然是哨兵淋巴結活體組織切片的主要應用，而哨兵淋巴結活體組織切片 (SNB) 已成為早期乳癌患者的標準治療方案。皮膚科和腫瘤內科也利用 SNB 進行黑色素瘤分期，準確評估淋巴結轉移。頭頸癌、婦科癌和前列腺癌領域的新應用正在進一步擴展 SNB 的應用範圍。此外，在新興市場的醫療保健提供者加大對腫瘤學基礎設施投資的支持下，他們正在將 SNB 作為改善癌症治療策略的一部分。

哪些因素推動了前哨淋巴結活體組織切片市場的成長？

前哨淋巴結活體組織切片市場的成長得益於癌症發病率的上升、微創診斷程序的日益普及以及影像技術的進步。政府推動早期癌症檢測和改善腫瘤診斷可近性的措施進一步推動了市場擴張。此外，人工智慧和機器學習在病理學中的應用正在提高前哨淋巴結活體組織切片的準確性，從而推動了腫瘤科醫生和外科醫生的需求。隨著精準醫療的不斷發展，前哨淋巴結活體組織切片有望在個人化癌症治療和預後診斷中發揮越來越重要的作用。

部分

產品（手術器械、診斷影像、診斷套件）；手術（開放性手術、微創手術）；應用（乳癌、結腸癌、食道癌、其他）；最終用途（醫院/診所、門診手術中心、診斷中心）

受訪公司範例

  • BD（Becton, Dickinson and Company）
  • Boston Scientific Corporation
  • CR Bard, Inc.
  • Cardinal Health
  • Care Wise
  • Devicor Medical Products, Inc.
  • Devicor Medical Products, Inc.
  • Endomagnetics Ltd（Endomag）
  • Gamma Medical Technology
  • Gamma Probe Technologies
  • GE Healthcare
  • Hologic, Inc.
  • Hologic, Inc.
  • Intramedical Imaging LLC
  • IsoRay Medical
  • KUB Technologies Inc.
  • KUB Technologies Inc.
  • LabLogic Systems Ltd（Care Wise）
  • LabLogic Systems Ltd（Care Wise）
  • LymphaTech
  • Medtronic
  • Navidea Biopharmaceuticals, Inc.
  • Philips Healthcare
  • Senti Biosciences
  • Siemens Healthineers
  • Stryker Corporation
  • Stryker Corporation
  • SurgicEye GmbH
  • SurgicEye GmbH
  • Varay Laborix

人工智慧整合

全球產業分析師利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global Industry Analysts 沒有遵循典型的 LLM 或特定於行業的 SLM查詢，而是建立了一個從世界各地的專家收集的內容庫，其中包括影片錄像、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地和進出口（成品和原始設備製造商）情況預測其競爭地位的變化。這種複雜而多面的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他地區

第4章 比賽

簡介目錄
Product Code: MCP32906

Global Sentinel Node Biopsy Market to Reach US$1.3 Billion by 2030

The global market for Sentinel Node Biopsy estimated at US$829.3 Million in the year 2024, is expected to reach US$1.3 Billion by 2030, growing at a CAGR of 7.1% over the analysis period 2024-2030. Surgical Instruments, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$732.2 Million by the end of the analysis period. Growth in the Imaging Agents segment is estimated at 6.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$218.0 Million While China is Forecast to Grow at 6.9% CAGR

The Sentinel Node Biopsy market in the U.S. is estimated at US$218.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$200.3 Million by the year 2030 trailing a CAGR of 6.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.7% and 5.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.6% CAGR.

Global Sentinel Node Biopsy Market - Key Trends & Drivers Summarized

Why Is Sentinel Node Biopsy Becoming A Crucial Procedure In Cancer Diagnostics?

Sentinel node biopsy (SNB) is a minimally invasive surgical procedure used to determine the spread of cancer, particularly in cases of breast cancer and melanoma. By identifying and analyzing the first lymph node (sentinel node) that cancer cells are likely to reach, SNB helps physicians assess metastasis without requiring a full lymph node dissection. This technique is gaining popularity due to its ability to reduce complications such as lymphedema while maintaining high diagnostic accuracy. With cancer rates rising globally and early detection playing a critical role in improving survival rates, the demand for sentinel node biopsy procedures is growing across healthcare institutions. Additionally, advancements in imaging and molecular diagnostics are further improving SNB precision and reliability.

What Technological Innovations Are Enhancing Sentinel Node Biopsy Procedures?

Recent advancements in radiotracer technology, fluorescence-guided surgery, and molecular imaging are revolutionizing sentinel node biopsy. The use of hybrid tracers combining radioactive and fluorescent dyes is improving detection rates, allowing surgeons to precisely locate sentinel lymph nodes. AI-assisted pathology analysis is further enhancing the accuracy of biopsy results, leading to better cancer staging and treatment planning. Additionally, robotic-assisted sentinel node biopsies are being explored to improve precision and minimize patient trauma. These technological breakthroughs are making SNB more efficient, accurate, and widely accessible in oncology practices.

Which Medical Sectors Are Driving The Growth Of Sentinel Node Biopsy?

Breast cancer diagnosis remains the leading application of sentinel node biopsy, with SNB becoming the standard of care for early-stage breast cancer patients. Dermatology and oncology practices are also utilizing SNB for melanoma staging, as it allows for precise assessment of lymph node involvement. Emerging applications in head and neck cancer, gynecologic cancers, and prostate cancer are further expanding the use of SNB. Additionally, healthcare providers in emerging markets are adopting SNB as part of improved cancer care strategies, supported by growing investments in oncology infrastructure.

What Factors Are Fueling The Growth Of The Sentinel Node Biopsy Market?

The growth of the sentinel node biopsy market is being driven by increasing cancer prevalence, rising adoption of minimally invasive diagnostic procedures, and advancements in imaging technology. Government initiatives promoting early cancer detection and improved access to oncology diagnostics are further supporting market expansion. Additionally, the integration of AI and machine learning in pathology is enhancing SNB accuracy, driving demand among oncologists and surgeons. As precision medicine continues to evolve, SNB will play an increasingly crucial role in personalized cancer treatment and prognosis.

SCOPE OF STUDY:

The report analyzes the Sentinel Node Biopsy market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Surgical Instruments, Imaging Agents, Diagnostic Kits); Procedure (Open Surgery, Minimally Invasive Surgery); Application (Breast Cancer, Colon Cancer, Esophageal Cancer, Others); End-Use (Hospitals & Clinics, Ambulatory Surgery Centers, Diagnostic Centers)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 39 Featured) -

  • BD (Becton, Dickinson and Company)
  • Boston Scientific Corporation
  • C.R. Bard, Inc.
  • Cardinal Health
  • Care Wise
  • Devicor Medical Products, Inc.
  • Devicor Medical Products, Inc.
  • Endomagnetics Ltd (Endomag)
  • Gamma Medical Technology
  • Gamma Probe Technologies
  • GE Healthcare
  • Hologic, Inc.
  • Hologic, Inc.
  • Intramedical Imaging LLC
  • IsoRay Medical
  • KUB Technologies Inc.
  • KUB Technologies Inc.
  • LabLogic Systems Ltd (Care Wise)
  • LabLogic Systems Ltd (Care Wise)
  • LymphaTech
  • Medtronic
  • Navidea Biopharmaceuticals, Inc.
  • Philips Healthcare
  • Senti Biosciences
  • Siemens Healthineers
  • Stryker Corporation
  • Stryker Corporation
  • SurgicEye GmbH
  • SurgicEye GmbH
  • Varay Laborix

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Sentinel Node Biopsy - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Demand for Early Cancer Detection Drives Growth in Sentinel Node Biopsy Procedures
    • Surge in Cancer Incidence Rates Expands Market Opportunities for Sentinel Node Biopsy Technologies
    • Technological Advancements in Imaging and Tracers Propel the Accuracy and Effectiveness of Sentinel Node Biopsy
    • Rising Awareness Among Healthcare Providers and Patients of the Benefits of Minimally Invasive Procedures Accelerates Adoption of Sentinel Node Biopsy
    • The Shift Toward Personalized Medicine and Tailored Cancer Treatments Drives Demand for Sentinel Node Biopsy Solutions
    • Increasing Focus on Reducing Surgical Complications and Recovery Times Strengthens the Business Case for Sentinel Node Biopsy
    • Surge in Breast Cancer and Melanoma Cases Drives the Demand for Sentinel Node Biopsy in Oncology Treatments
    • Expansion of Cancer Immunotherapy and Targeted Therapies Fuels Market Growth for Sentinel Node Biopsy Procedures
    • Rising Investment in Advanced Cancer Diagnostics and Staging Technologies Expands Market Potential for Sentinel Node Biopsy
    • Increasing Integration of Artificial Intelligence in Imaging and Diagnostic Technologies Drives Adoption of Sentinel Node Biopsy Solutions
    • Regulatory Support and Approvals for Non-Invasive and Less Invasive Diagnostic Methods Strengthen Demand for Sentinel Node Biopsy Procedures
    • Increasing Preference for Lymph Node Staging Techniques That Minimize Patient Discomfort Drives Adoption of Sentinel Node Biopsy
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Sentinel Node Biopsy Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Sentinel Node Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Surgical Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Surgical Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Imaging Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Imaging Agents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Diagnostic Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Diagnostic Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Open Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Open Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Minimally Invasive Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Minimally Invasive Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Breast Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Breast Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Colon Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Colon Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Esophageal Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Esophageal Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World 6-Year Perspective for Others by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Sentinel Node Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 28: USA Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Product - Surgical Instruments, Imaging Agents and Diagnostic Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 29: USA 6-Year Perspective for Sentinel Node Biopsy by Product - Percentage Breakdown of Value Sales for Surgical Instruments, Imaging Agents and Diagnostic Kits for the Years 2025 & 2030
    • TABLE 30: USA Recent Past, Current & Future Analysis for Sentinel Node Biopsy by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: USA 6-Year Perspective for Sentinel Node Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Procedure - Open Surgery and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA 6-Year Perspective for Sentinel Node Biopsy by Procedure - Percentage Breakdown of Value Sales for Open Surgery and Minimally Invasive Surgery for the Years 2025 & 2030
    • TABLE 34: USA Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Application - Breast Cancer, Colon Cancer, Esophageal Cancer and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: USA 6-Year Perspective for Sentinel Node Biopsy by Application - Percentage Breakdown of Value Sales for Breast Cancer, Colon Cancer, Esophageal Cancer and Others for the Years 2025 & 2030
  • CANADA
    • TABLE 36: Canada Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Product - Surgical Instruments, Imaging Agents and Diagnostic Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Canada 6-Year Perspective for Sentinel Node Biopsy by Product - Percentage Breakdown of Value Sales for Surgical Instruments, Imaging Agents and Diagnostic Kits for the Years 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Sentinel Node Biopsy by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada 6-Year Perspective for Sentinel Node Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 40: Canada Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Procedure - Open Surgery and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Canada 6-Year Perspective for Sentinel Node Biopsy by Procedure - Percentage Breakdown of Value Sales for Open Surgery and Minimally Invasive Surgery for the Years 2025 & 2030
    • TABLE 42: Canada Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Application - Breast Cancer, Colon Cancer, Esophageal Cancer and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Canada 6-Year Perspective for Sentinel Node Biopsy by Application - Percentage Breakdown of Value Sales for Breast Cancer, Colon Cancer, Esophageal Cancer and Others for the Years 2025 & 2030
  • JAPAN
    • Sentinel Node Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Product - Surgical Instruments, Imaging Agents and Diagnostic Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan 6-Year Perspective for Sentinel Node Biopsy by Product - Percentage Breakdown of Value Sales for Surgical Instruments, Imaging Agents and Diagnostic Kits for the Years 2025 & 2030
    • TABLE 46: Japan Recent Past, Current & Future Analysis for Sentinel Node Biopsy by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Japan 6-Year Perspective for Sentinel Node Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 48: Japan Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Procedure - Open Surgery and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Japan 6-Year Perspective for Sentinel Node Biopsy by Procedure - Percentage Breakdown of Value Sales for Open Surgery and Minimally Invasive Surgery for the Years 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Application - Breast Cancer, Colon Cancer, Esophageal Cancer and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan 6-Year Perspective for Sentinel Node Biopsy by Application - Percentage Breakdown of Value Sales for Breast Cancer, Colon Cancer, Esophageal Cancer and Others for the Years 2025 & 2030
  • CHINA
    • Sentinel Node Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 52: China Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Product - Surgical Instruments, Imaging Agents and Diagnostic Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: China 6-Year Perspective for Sentinel Node Biopsy by Product - Percentage Breakdown of Value Sales for Surgical Instruments, Imaging Agents and Diagnostic Kits for the Years 2025 & 2030
    • TABLE 54: China Recent Past, Current & Future Analysis for Sentinel Node Biopsy by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: China 6-Year Perspective for Sentinel Node Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Procedure - Open Surgery and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China 6-Year Perspective for Sentinel Node Biopsy by Procedure - Percentage Breakdown of Value Sales for Open Surgery and Minimally Invasive Surgery for the Years 2025 & 2030
    • TABLE 58: China Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Application - Breast Cancer, Colon Cancer, Esophageal Cancer and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: China 6-Year Perspective for Sentinel Node Biopsy by Application - Percentage Breakdown of Value Sales for Breast Cancer, Colon Cancer, Esophageal Cancer and Others for the Years 2025 & 2030
  • EUROPE
    • Sentinel Node Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 60: Europe Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 61: Europe 6-Year Perspective for Sentinel Node Biopsy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Product - Surgical Instruments, Imaging Agents and Diagnostic Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe 6-Year Perspective for Sentinel Node Biopsy by Product - Percentage Breakdown of Value Sales for Surgical Instruments, Imaging Agents and Diagnostic Kits for the Years 2025 & 2030
    • TABLE 64: Europe Recent Past, Current & Future Analysis for Sentinel Node Biopsy by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Europe 6-Year Perspective for Sentinel Node Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 66: Europe Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Procedure - Open Surgery and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Europe 6-Year Perspective for Sentinel Node Biopsy by Procedure - Percentage Breakdown of Value Sales for Open Surgery and Minimally Invasive Surgery for the Years 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Application - Breast Cancer, Colon Cancer, Esophageal Cancer and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe 6-Year Perspective for Sentinel Node Biopsy by Application - Percentage Breakdown of Value Sales for Breast Cancer, Colon Cancer, Esophageal Cancer and Others for the Years 2025 & 2030
  • FRANCE
    • Sentinel Node Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 70: France Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Product - Surgical Instruments, Imaging Agents and Diagnostic Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: France 6-Year Perspective for Sentinel Node Biopsy by Product - Percentage Breakdown of Value Sales for Surgical Instruments, Imaging Agents and Diagnostic Kits for the Years 2025 & 2030
    • TABLE 72: France Recent Past, Current & Future Analysis for Sentinel Node Biopsy by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: France 6-Year Perspective for Sentinel Node Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 74: France Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Procedure - Open Surgery and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: France 6-Year Perspective for Sentinel Node Biopsy by Procedure - Percentage Breakdown of Value Sales for Open Surgery and Minimally Invasive Surgery for the Years 2025 & 2030
    • TABLE 76: France Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Application - Breast Cancer, Colon Cancer, Esophageal Cancer and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: France 6-Year Perspective for Sentinel Node Biopsy by Application - Percentage Breakdown of Value Sales for Breast Cancer, Colon Cancer, Esophageal Cancer and Others for the Years 2025 & 2030
  • GERMANY
    • Sentinel Node Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 78: Germany Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Product - Surgical Instruments, Imaging Agents and Diagnostic Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Germany 6-Year Perspective for Sentinel Node Biopsy by Product - Percentage Breakdown of Value Sales for Surgical Instruments, Imaging Agents and Diagnostic Kits for the Years 2025 & 2030
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Sentinel Node Biopsy by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Germany 6-Year Perspective for Sentinel Node Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 82: Germany Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Procedure - Open Surgery and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Germany 6-Year Perspective for Sentinel Node Biopsy by Procedure - Percentage Breakdown of Value Sales for Open Surgery and Minimally Invasive Surgery for the Years 2025 & 2030
    • TABLE 84: Germany Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Application - Breast Cancer, Colon Cancer, Esophageal Cancer and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Germany 6-Year Perspective for Sentinel Node Biopsy by Application - Percentage Breakdown of Value Sales for Breast Cancer, Colon Cancer, Esophageal Cancer and Others for the Years 2025 & 2030
  • ITALY
    • TABLE 86: Italy Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Product - Surgical Instruments, Imaging Agents and Diagnostic Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Italy 6-Year Perspective for Sentinel Node Biopsy by Product - Percentage Breakdown of Value Sales for Surgical Instruments, Imaging Agents and Diagnostic Kits for the Years 2025 & 2030
    • TABLE 88: Italy Recent Past, Current & Future Analysis for Sentinel Node Biopsy by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Italy 6-Year Perspective for Sentinel Node Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 90: Italy Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Procedure - Open Surgery and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Italy 6-Year Perspective for Sentinel Node Biopsy by Procedure - Percentage Breakdown of Value Sales for Open Surgery and Minimally Invasive Surgery for the Years 2025 & 2030
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Application - Breast Cancer, Colon Cancer, Esophageal Cancer and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Italy 6-Year Perspective for Sentinel Node Biopsy by Application - Percentage Breakdown of Value Sales for Breast Cancer, Colon Cancer, Esophageal Cancer and Others for the Years 2025 & 2030
  • UNITED KINGDOM
    • Sentinel Node Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 94: UK Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Product - Surgical Instruments, Imaging Agents and Diagnostic Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 95: UK 6-Year Perspective for Sentinel Node Biopsy by Product - Percentage Breakdown of Value Sales for Surgical Instruments, Imaging Agents and Diagnostic Kits for the Years 2025 & 2030
    • TABLE 96: UK Recent Past, Current & Future Analysis for Sentinel Node Biopsy by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 97: UK 6-Year Perspective for Sentinel Node Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 98: UK Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Procedure - Open Surgery and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: UK 6-Year Perspective for Sentinel Node Biopsy by Procedure - Percentage Breakdown of Value Sales for Open Surgery and Minimally Invasive Surgery for the Years 2025 & 2030
    • TABLE 100: UK Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Application - Breast Cancer, Colon Cancer, Esophageal Cancer and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 101: UK 6-Year Perspective for Sentinel Node Biopsy by Application - Percentage Breakdown of Value Sales for Breast Cancer, Colon Cancer, Esophageal Cancer and Others for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 102: Rest of Europe Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Product - Surgical Instruments, Imaging Agents and Diagnostic Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 103: Rest of Europe 6-Year Perspective for Sentinel Node Biopsy by Product - Percentage Breakdown of Value Sales for Surgical Instruments, Imaging Agents and Diagnostic Kits for the Years 2025 & 2030
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Sentinel Node Biopsy by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Europe 6-Year Perspective for Sentinel Node Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 106: Rest of Europe Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Procedure - Open Surgery and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 107: Rest of Europe 6-Year Perspective for Sentinel Node Biopsy by Procedure - Percentage Breakdown of Value Sales for Open Surgery and Minimally Invasive Surgery for the Years 2025 & 2030
    • TABLE 108: Rest of Europe Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Application - Breast Cancer, Colon Cancer, Esophageal Cancer and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 109: Rest of Europe 6-Year Perspective for Sentinel Node Biopsy by Application - Percentage Breakdown of Value Sales for Breast Cancer, Colon Cancer, Esophageal Cancer and Others for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Sentinel Node Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Product - Surgical Instruments, Imaging Agents and Diagnostic Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific 6-Year Perspective for Sentinel Node Biopsy by Product - Percentage Breakdown of Value Sales for Surgical Instruments, Imaging Agents and Diagnostic Kits for the Years 2025 & 2030
    • TABLE 112: Asia-Pacific Recent Past, Current & Future Analysis for Sentinel Node Biopsy by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 113: Asia-Pacific 6-Year Perspective for Sentinel Node Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 114: Asia-Pacific Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Procedure - Open Surgery and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 115: Asia-Pacific 6-Year Perspective for Sentinel Node Biopsy by Procedure - Percentage Breakdown of Value Sales for Open Surgery and Minimally Invasive Surgery for the Years 2025 & 2030
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Application - Breast Cancer, Colon Cancer, Esophageal Cancer and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific 6-Year Perspective for Sentinel Node Biopsy by Application - Percentage Breakdown of Value Sales for Breast Cancer, Colon Cancer, Esophageal Cancer and Others for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 118: Rest of World Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Product - Surgical Instruments, Imaging Agents and Diagnostic Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 119: Rest of World 6-Year Perspective for Sentinel Node Biopsy by Product - Percentage Breakdown of Value Sales for Surgical Instruments, Imaging Agents and Diagnostic Kits for the Years 2025 & 2030
    • TABLE 120: Rest of World Recent Past, Current & Future Analysis for Sentinel Node Biopsy by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 121: Rest of World 6-Year Perspective for Sentinel Node Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 122: Rest of World Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Procedure - Open Surgery and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of World 6-Year Perspective for Sentinel Node Biopsy by Procedure - Percentage Breakdown of Value Sales for Open Surgery and Minimally Invasive Surgery for the Years 2025 & 2030
    • TABLE 124: Rest of World Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Application - Breast Cancer, Colon Cancer, Esophageal Cancer and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 125: Rest of World 6-Year Perspective for Sentinel Node Biopsy by Application - Percentage Breakdown of Value Sales for Breast Cancer, Colon Cancer, Esophageal Cancer and Others for the Years 2025 & 2030

IV. COMPETITION